FindTrial
Sign In

A randomized prospective study comparing the efficacy of dexmedetomidine versus midazolam administered through the nasal route for sedation in pediatric patients

A randomized prospective study comparing intranasal dexmedetomidine versus intranasal midazolam for sedation in pediatric patients. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073323
Enrollment
80
Registered
2024-09-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Intranasal Midazolam: Intranasal midazolam is used as a sedative medication in pediatric patients undergoing any operative procedure or environment. Before entering any operative or pro

Sponsors

SUBHARTI MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 ASA CLASS I & II 2 Age from 1-12yrs. 3 Patients of either sex.

Exclusion criteria

Exclusion criteria: 1 Children with an allergy to the study drug. 2 Children with organ dysfunction. 3 Children with any congenital heart disease. 4. Refusal by the parents.

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of intranasal dexmedetomidine and intranasal midazolam in pediatric patient for sedation.Timepoint: 40mins—

Secondary

MeasureTime frame
1 To compare hemodynamic changes in both the groups. 2 To compare side effects in both the groups, if any.Timepoint: 40 MINS.—

Countries

India

Contacts

Public ContactDr Neetu Yadav

Subharti medical college and hospital

neetuyadav445@gmail.com9958421762

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026